147 related articles for article (PubMed ID: 24460730)
1. Characteristics of sebaceous carcinoma and early outcomes of treatment using Mohs micrographic surgery versus wide local excision: an update of the Mayo Clinic experience over the past 2 decades.
Hou JL; Killian JM; Baum CL; Otley CC; Roenigk RK; Arpey CJ; Weaver AL; Brewer JD
Dermatol Surg; 2014 Mar; 40(3):241-6. PubMed ID: 24460730
[TBL] [Abstract][Full Text] [Related]
2. Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery.
Spencer JM; Nossa R; Tse DT; Sequeira M
J Am Acad Dermatol; 2001 Jun; 44(6):1004-9. PubMed ID: 11369914
[TBL] [Abstract][Full Text] [Related]
3. Sebaceous carcinoma of the eyelids treated by mohs micrographic surgery: report of nine cases with review of the literature.
Snow SN; Larson PO; Lucarelli MJ; Lemke BN; Madjar DD
Dermatol Surg; 2002 Jul; 28(7):623-31. PubMed ID: 12135523
[TBL] [Abstract][Full Text] [Related]
4. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.
Zhou C; Wu F; Chai P; Shi Y; Ye J; Shi X; Tan J; Ding Y; Luo Y; Esmaeli B; Jia R; Fan X
J Am Acad Dermatol; 2019 Jun; 80(6):1608-1617.e1. PubMed ID: 30639290
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Mohs Micrographic Surgery and Wide Local Excision for Treatment of Dermatofibrosarcoma Protuberans With Long-Term Follow-up: The Mayo Clinic Experience.
Lowe GC; Onajin O; Baum CL; Otley CC; Arpey CJ; Roenigk RK; Brewer JD
Dermatol Surg; 2017 Jan; 43(1):98-106. PubMed ID: 27749444
[TBL] [Abstract][Full Text] [Related]
6. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
[TBL] [Abstract][Full Text] [Related]
7. Sebaceous Carcinoma of the Face Treated With Mohs Micrographic Surgery.
Meer E; Nguyen B; Luna GL; Kim D; Bautista S; McGeehan B; Giordano C; Etzkorn J; Miller C; Briceño CA
Dermatol Surg; 2022 Nov; 48(11):1148-1154. PubMed ID: 36194726
[TBL] [Abstract][Full Text] [Related]
8. Cystic sebaceous carcinoma: is it a constant pathognomic marker for Muir-Torre syndrome?
Al-Shobaili HA; AlGhamdi KM; Al-Ghamdi WA
J Drugs Dermatol; 2007 May; 6(5):540-3. PubMed ID: 17679191
[TBL] [Abstract][Full Text] [Related]
9. Mohs micrographic surgery versus wide local excision for sebaceous adenocarcinoma of the eyelid : Analysis of a national database.
Phan K; Loya A
J Plast Reconstr Aesthet Surg; 2019 Jun; 72(6):1007-1011. PubMed ID: 30894313
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes for malignant melanoma of the face treated using Mohs micrographic surgery and wide local excision.
Chin-Lenn L; Murynka T; McKinnon JG; Arlette JP
Dermatol Surg; 2013 Nov; 39(11):1637-45. PubMed ID: 24164702
[TBL] [Abstract][Full Text] [Related]
12. Sebaceous carcinoma: the great masquerader: emgerging concepts in diagnosis and treatment.
Buitrago W; Joseph AK
Dermatol Ther; 2008; 21(6):459-66. PubMed ID: 19076624
[TBL] [Abstract][Full Text] [Related]
13. Sebaceous carcinoma of the eyelid: a review of 14 cases.
Callahan EF; Appert DL; Roenigk RK; Bartley GB
Dermatol Surg; 2004 Aug; 30(8):1164-8. PubMed ID: 15274713
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
15. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience.
Thomas CJ; Wood GC; Marks VJ
Dermatol Surg; 2007 Mar; 33(3):333-9. PubMed ID: 17338692
[TBL] [Abstract][Full Text] [Related]
16. More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?
Ang GC; Roenigk RK; Otley CC; Kim Phillips P; Weaver AL
Dermatol Surg; 2009 May; 35(5):765-72. PubMed ID: 19389106
[TBL] [Abstract][Full Text] [Related]
17. Localized sebaceous carcinoma treatment: Wide local excision verses Mohs micrographic surgery.
Elias ML; Skula SR; Behbahani S; Lambert WC; Schwartz RA
Dermatol Ther; 2020 Nov; 33(6):e13991. PubMed ID: 32645237
[TBL] [Abstract][Full Text] [Related]
18. Primary mucinous carcinoma of the skin: the Mayo Clinic experience over the past 2 decades.
Adefusika JA; Pimentel JD; Chavan RN; Brewer JD
Dermatol Surg; 2015 Feb; 41(2):201-8. PubMed ID: 25627628
[TBL] [Abstract][Full Text] [Related]
19. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
20. Management Considerations in Extraocular Sebaceous Carcinoma.
Chang AY; Miller CJ; Elenitsas R; Newman JG; Sobanko JF
Dermatol Surg; 2016 Jan; 42 Suppl 1():S57-65. PubMed ID: 26730975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
